Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Top Cited Papers
Open Access
- 30 September 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (9), 1650-1656
- https://doi.org/10.1038/mt.2010.136
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cellsMolecular Cancer Therapeutics, 2007
- MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cellsOncogene, 2007
- Identification of Clinically Significant Tumor Antigens by Selecting Phage Antibody Library on Tumor Cells in Situ Using Laser Capture MicrodissectionMolecular & Cellular Proteomics, 2006
- Construction of human ScFv phage display library against ovarian tumor.Journal of Huazhong University of Science and Technology [Medical Sciences], 2006
- MicroRNA therapeutics: a new niche for antisense nucleic acidsTrends in Molecular Medicine, 2006
- Clarifications on miRNA and CancerScience, 2006
- MicroRNA: Biogenetic and Functional Mechanisms and Involvements in Cell Differentiation and CancerJournal of Pharmacological Sciences, 2006
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptorJournal of Neuroimmunology, 1999